VACCINE COMPOSITIONS AND METHODS OF USE THEREOF Russian patent published in 2016 - IPC A61K39/38 

Abstract RU 2600798 C2

FIELD: immunology.

SUBSTANCE: group of inventions discloses a vaccine containing a charged highly branched polymer dendrimer which is a PAMAM-dendrimer conjugated with at least one T-helper peptide and nucleic acid coding at least one antigen, where the T-helper peptide and nucleic acid are conjugated with the outer surface of the PAMAM-dendrimer so that the T-helper peptide specifically binds to professional antigen processing cells and the combination of at least one T-helper peptide, PAMAM-dendrimer and nucleic acid is able to induce an immune response to at least one antigen, as well as the method for delivering an antigen into a mammal organism and also induce the production of monoclonal antibodies to an antigen in a mammal organism. Vaccines and methods described in this invention have a preventive as well as therapeutic application.

EFFECT: vaccine as described herein can be used to mount an immune response against any infectious pathogen or cancer.

22 cl, 18 dwg, 7 ex

Similar patents RU2600798C2

Title Year Author Number
POLYEPITOPE ANTI-TUMOUR VACCINE STRUCTURE CONTAINING EPITOPES OF TUMOR-ASSOCIATED ANTIGENS, PHARMACEUTICAL COMPOSITION AND ITS APPLICATION FOR STIMULATING SPECIFIC ANTI-TUMOR IMMUNE RESPONSE 2016
  • Sennikov Sergej Vitalevich
  • Maksyutov Amir Zakievich
  • Maksyutov Rinat Amirovich
  • Bakulina Anastasiya Yurevna
  • Gavrilova Elena Vasilevna
  • Kurilin Vasilij Vasilevich
  • Lopatnikova Yuliya Anatolevna
  • Shevchenko Yuliya Aleksandrovna
  • Obleukhova Irina Aleksandrovna
  • Kulikova Ekaterina Vladimirovna
  • Sokolov Andrej Viktorovich
  • Khristin Aleksandr Aleksandrovich
  • Sidorov Sergej Vasilevich
  • Kalichkin Andrej Alekseevich
  • Kozlov Vadim Viktorovich
  • Kiryushina Natalya Anatolevna
  • Cherkasov Andrej Pavlovich
RU2684235C2
NOVEL CELL-PENETRATING PEPTIDES 2013
  • Deruazi Madia
  • Uolker Pol
  • Ditrikh Per-Iv
RU2670488C2
IMMUNOGENIC COMPOSITION AND METHOD OF FUSED PROTEIN VACCINE DEVELOPMENT 2004
  • Karp Nelson M.
RU2407749C2
IMMUNE STIMULATING AND VACCINE COMPOSITIONS 2011
  • Petersh Dzheffri Alan
RU2578420C2
IDENTIFICATION OF TUMOUR-ASSOCIATED ANTIGENS FOR DIAGNOSTICS AND THERAPY 2013
  • Sakhin Ugur
  • Tyurechi Ezlem
  • Kozlovski Mikhael
  • Uzener Dirk
RU2644686C2
AGENTS AND METHODS BASED ON USING FIBRONECTIN OF DOMAIN EDA 2006
  • Lekler Klod
  • Lasarte-Sagastibel'Sa Khuan-Khose
  • Gorrais-Ajala Marta
  • Prieto-Val'Tuehn'Ja Khesus
RU2430738C2
METHODS OF PREDICTING THE APPLICABILITY OF DISEASE-SPECIFIC AMINO ACID MODIFICATIONS FOR IMMUNOTHERAPY 2018
  • Sakhin, Ugur
RU2799341C2
DNA COMPOSITION FOR INDUCING IMMUNE RESPONSE ON TUMOUR-ASSOCIATED MACROPHAGUES 2007
  • Rejsfeld Ral'F A.
  • Sjan Zhun
  • Lo Jun'Pin
RU2459631C2
MODIFIED EPITOPES FOR AMPLIFYING RESPONSES OF CD4+ T-CELLS 2013
  • Sen-Remi Zhan-Mari
RU2724994C2
IMMUNOGENIC COMPOSITIONS OF MULTIPLE ANTIGEN PRESENTATION, METHODS AND APPLICATIONS RELATING THERETO 2012
  • Molli Richard
  • Lu Intsze
  • Chzan Fan
RU2619176C2

RU 2 600 798 C2

Authors

Daftarian Piruz Mokhammad

Serafini Paolo

Lemmon Vens Pol

Li Vej

Kejfer Ejndzhel

Blomberg Bonni Bet

Peres Viktor L.

Dates

2016-10-27Published

2010-04-01Filed